Consecutive Use of T
Consecutive Use of TNF-Inhibitors for the Treatment of Psoriatic Arthritis at Lowest Point Recorded, as Use of Biologics with Alternate Mechanisms of Actions Continue to Grow, According to Spherix Global Insights
03 oct. 2023 13h57 HE | Spherix Global Insights
Exton, Pennsylvania, Oct. 03, 2023 (GLOBE NEWSWIRE) -- US rheumatologists (n=204) report nearly two-thirds of their psoriatic arthritis (PsA) patients are undergoing treatment with advanced systemic...
Moonlake logo.png
MoonLake completes patient randomization ahead of schedule for its Phase 2 trial in active psoriatic arthritis (PsA) and provides calendar of next readouts  
25 juil. 2023 08h00 HE | MoonLake Immunotherapeutics AG
MoonLake completes patient randomization ahead of schedule for its Phase 2 trial in active psoriatic arthritis (PsA) and provides calendar of next readoutsRandomization target of 200 patients...
MicrosoftTeams-image (5).png
Psoriatic Arthritis Therapeutics Market to Grow at a CAGR of 8.0% from 2022 to 2031, reaching USD 24.2 Billion: As per TMR Study
23 juin 2023 16h30 HE | Transparency Market Research
Wilmington, Delaware, United States, June 24, 2023 (GLOBE NEWSWIRE) -- The global psoriatic arthritis therapeutics market stood at USD 10.8 billion in 2021, and the global market is projected to...
Logo.png
Psoriatic Arthritis Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 30+ Companies Working in the Domain
07 déc. 2022 13h00 HE | DelveInsight Business Research LLP
New York, USA, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Psoriatic Arthritis Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 30+ Companies Working in the Domain The...
With 9.5% CAGR, Psoriatic Arthritis Treatment Market Size Hit USD 13.12 Billion in 2027
23 nov. 2022 05h55 HE | Fortune Business Insights
Pune, India, Nov. 23, 2022 (GLOBE NEWSWIRE) -- The global psoriatic arthritis treatment market size is anticipated to touch USD 13.12 billion by the end of 2027 on account of the increasing...
AMR Logo.png
Global Psoriasis Therapeutics Market to Reach $55.8 Billion by 2031: Says AMR
23 oct. 2022 03h30 HE | Allied Market Research
Portland, OR, Oct. 23, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Psoriasis Therapeutics Market was estimated at $22.9 billion in 2021 and is...
22157.jpg
Biosimilars in Immunology Prescriber Opinions Survey 2021 - Factors Influencing Choice of Prescribed Biosimilar Brands
20 janv. 2022 05h58 HE | Research and Markets
Dublin, Jan. 20, 2022 (GLOBE NEWSWIRE) -- The "Prescriber Opinions on Biosimilars in Immunology" report has been added to ResearchAndMarkets.com's offering. This report covers the 7MM (United...
22157.jpg
Psoriatic Arthritis Treatment Global Market Report 2020-2030: COVID-19 Growth and Changes
22 déc. 2020 05h53 HE | Research and Markets
Dublin, Dec. 22, 2020 (GLOBE NEWSWIRE) -- The "Psoriatic Arthritis Treatment Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. ...
FBI LOGO TM.png
Psoriatic Arthritis Treatment Market to Exhibit 9.5% CAGR and Reach $13.12 Billion: Advanced Predictive Analytics offered by RCM to Boost Growth
09 sept. 2020 06h18 HE | Fortune Business Insights
Pune, Sept. 09, 2020 (GLOBE NEWSWIRE) -- The global psoriatic arthritis treatment market size is anticipated to touch USD 13.12 billion by the end of 2027 on account of the increasing prevalence of...
National Rheumatolog
National Rheumatology and Psoriasis Organizations Release Joint Guideline for Treating Psoriatic Arthritis
03 déc. 2018 17h04 HE | American College of Rheumatology
Atlanta, Dec. 03, 2018 (GLOBE NEWSWIRE) -- The American College of Rheumatology (ACR) and National Psoriasis Foundation (NPF) have released a joint treatment guideline for psoriatic arthritis (PsA)...